Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Miller who wrote (2874)	5/20/1999 1:41:00 PM
From: Biomaven	Read Replies (1) of 10280

Interestingly enough, the SEPR ICE for sibutramine is also a norepinephrine reuptake inhibitor (as well as for serotonin and dopamine). This unique triple action (sounds like a detergent commercial <g>) is what makes them so excited. My take on this weakness is that it is still fallout from the J&J nora deal. The number-cruncher sorts have probably reduced or pushed out the expected earnings from nora (or increased their discount rate) and this has a fair effect on the near term earnings. There are also a species of shorts that go for "high priced" (i.e., no earnings, low book value) stocks with negative price momentum, and they might be piling on here. The long term value of the company remains essentially unaffected in my view. If you are prepared to take a 3 to 4 year view, I do not think you will go unrewarded by purchases at the current price. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next